FTC sues to block Edwards Lifesciences' $1.2B JenaValve deal. Edwards disputes, revises 2025 EPS guidance, and pursues ...

The U.S. Federal Trade Commission has sued to block Edwards Lifesciences Corp's acquisition of JenaValve Technology Inc, ...

Inc. ("Venus Medtech", Stock Code: 02500.HK) recently announced a decisive legal victory for its wholly-owned subsidiary ...

CEO Christian Mazzi said the minimally invasive surgical technique could provide better outcomes for patients than ...

Edwards Lifesciences may avoid bearishness but is likely to trade sluggishly through 2027, as key cycle phases signal limited ...

In its own statement, Edwards said it disagrees with the FTC’s belief that the acquisition will limit access to a new therapy ...

Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

Edwards Lifesciences announced that the U.S. Federal Trade Commission (FTC) seeks to block its planned $1.2 billion ...

Baron Capital’s Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and ...

Larry Wood, who was the executive behind building the biggest unit during his four decades at Edwards Lifesciences, is ...

Edwards Lifesciences' (NYSE:EW) stock is up by 5.9% over the past three months. Since the market usually pay for ...